Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Invesco S&P 500 Revenue ETF
RWL
|
$658M |
| 2 |
Tesla
TSLA
|
$573M |
| 3 |
Bank of America
BAC
|
$480M |
| 4 |
Amazon
AMZN
|
$448M |
| 5 |
Canadian Pacific Kansas City
CP
|
$445M |
Top Sells
| 1 |
Invesco S&P 500 Pure Value ETF
RPV
|
$493M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$395M |
| 3 |
Eli Lilly
LLY
|
$364M |
| 4 |
CME Group
CME
|
$316M |
| 5 |
T-Mobile US
TMUS
|
$310M |
Sector Composition
| 1 | Technology | 23.42% |
| 2 | Financials | 13.31% |
| 3 | Industrials | 11.28% |
| 4 | Healthcare | 10.55% |
| 5 | Consumer Discretionary | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3651
ProQR Therapeutics
PRQR
$241M
| $24.1K | ﹤0.01% |
18,084
+6,197
| +52% | +$8.24K |
|
3652
BRC Inc
BRCC
$175M
| $24K | ﹤0.01% |
11,487
-958
| -8% | -$2K |
|
3653
LiveOne
LVO
$58.1M
| $23.4K | ﹤0.01% |
33,503
+136
| +0.4% | +$95 |
|
3654
Biomea Fusion
BMEA
$121M
| $23.3K | ﹤0.01% |
10,959
-649
| -6% | -$1.38K |
|
3655
FiscalNote
NOTE
$873M
| $21.9K | ﹤0.01% |
27,081
-1,170
| -4% | -$945 |
|
|
KG
3656
Kestrel Group, Ltd.
KG
$204M
| $21.5K | ﹤0.01% |
37,716
-1,409
| -4% | -$804 |
|
3657
Cassava Sciences
SAVA
$110M
| $19.7K | ﹤0.01% |
13,117
-2,291
| -15% | -$3.44K |
|
3658
Tevogen Bio Holdings
TVGN
$175M
| $19.2K | ﹤0.01% |
17,819
+796
| +5% | +$860 |
|
3659
Inovio Pharmaceuticals
INO
$137M
| $19.2K | ﹤0.01% |
11,779
-258
| -2% | -$421 |
|
3660
GrowGeneration
GRWG
$98M
| $19K | ﹤0.01% |
17,608
-877
| -5% | -$947 |
|
3661
Shattuck Labs
STTK
$48.4M
| $18K | ﹤0.01% |
18,908
+182
| +1% | +$173 |
|
|
INZY
3662
DELISTED
Inozyme Pharma
INZY
| $17.6K | ﹤0.01% |
19,315
-592
| -3% | -$539 |
|
3663
Renovaro
RENB
$52.5M
| $15.9K | ﹤0.01% |
29,269
+202
| +0.7% | +$110 |
|
|
ADAP
3664
Adaptimmune Therapeutics
ADAP
$15.3M
| $15.4K | ﹤0.01% |
78,031
+14,696
| +23% | +$2.9K |
|
3665
Nautilus Biotechnolgy
NAUT
$85M
| $14.7K | ﹤0.01% |
17,101
-780
| -4% | -$672 |
|
3666
Werewolf Therapeutics
HOWL
$59.4M
| $13.8K | ﹤0.01% |
14,232
-357
| -2% | -$347 |
|
3667
X4 Pharmaceuticals
XFOR
$77.9M
| $13.8K | ﹤0.01% |
58,187
-3,886
| -6% | -$919 |
|
3668
FibroBiologics
FBLG
$26M
| $11.4K | ﹤0.01% |
12,659
| – | – |
|
3669
Harvard Bioscience
HBIO
$21.8M
| $9.57K | ﹤0.01% |
16,899
-505
| -3% | -$286 |
|
3670
374Water
SCWO
$51.9M
| $9.17K | ﹤0.01% |
26,971
| – | – |
|
3671
Ovid Therapeutics
OVID
$87.5M
| $8.49K | ﹤0.01% |
27,207
| – | – |
|
|
AMRN
3672
Amarin Corp
AMRN
$314M
| $7.51K | ﹤0.01% |
16,748
-21
| -0.1% | -$9 |
|
3673
MarketWise
MKTW
$49.3M
| $6.96K | ﹤0.01% |
14,106
+525
| +4% | +$259 |
|
3674
Tenaya Therapeutics
TNYA
$176M
| $6.96K | ﹤0.01% |
12,209
-667
| -5% | -$380 |
|
|
ELEV
3675
DELISTED
Elevation Oncology
ELEV
| $6.51K | ﹤0.01% |
25,113
+318
| +1% | +$82 |
|